MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2025.1665906

Медицинская библиотека · Frontiers in immunology · 2025

Dendritic cell-related gene signature in pancreatic cancer stratifies patient subtypes and implicates a KCTD14-TNF signaling axis.

Liang Yuxin, Gu Yuheng, Zhang Zilong, Zhong Deyuan, Yan Hongtao, Su Yuhao, Chen Yahui, Wang Fei, Leng Zhengwei, Huang Xiaolun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Pancreatic cancer (PC) is characterized by a profoundly immunosuppressive tumor microenvironment and poor prognosis. Dendritic cells (DCs) are pivotal for antigen presentation and T-cell activation, yet their prognostic and mechanistic roles in PC remain incompletely defined.

METHODS

This study performed weighted gene co-expression network analysis (WGCNA) on transcriptomic data from The Cancer Genome Atlas (TCGA) and two Gene Expression Omnibus cohorts (GSE62165, GSE85916) to identify DC-related gene modules. Consensus clustering based on these modules stratified patients into two immune phenotypes. A four-gene DC-related risk score (DCRS) was constructed using LASSO-Cox regression and validated in independent cohorts. Single-cell RNA sequencing data from 25 PC samples (GSE242230) were analyzed through cell clustering analysis, cell-cell communication analysis, and pathway-specific analysis. Functional assays following KCTD14 knockdown in CAPAN-1 and PANC-1 cell lines assessed its impact on proliferation, migration, invasion, and TNF signaling.

RESULTS

WGCNA identified 130 overlapping DC-related genes enriched in immune pathways. Two DC-related patient clusters exhibited distinct overall survival (OS) (P < 0.05). The DCRS robustly stratified patients into high- and low-risk groups in both TCGA training and validation sets. DCRS demonstrated good predictive potential for OS and there is a significant difference in OS between the two groups of patients (P < 0.05). Single-cell analysis revealed KCTD14 enrichment in malignant epithelial cells and predicted its interaction with DCs via the TNF-TNFRSF1A axis. In vitro, KCTD14 knockdown significantly reduced PC cell proliferation, colony formation, migration, and invasion, and downregulated TNF-α and TNFRSF1A expression (P < 0.01).

CONCLUSION

We identified a novel DC-related gene signature that stratifies PC patients by prognosis and highlights KCTD14 as a novel immunomodulatory oncogene acting through the TNF-TNFR1 axis. Our findings provide a foundation for integrating DCRS into clinical risk assessment and for pursuing KCTD14/TNFR1-targeted therapies to overcome DC-mediated immune suppression in pancreatic cancer.

Для цитирования: Liang Yuxin, Gu Yuheng, Zhang Zilong, Zhong Deyuan, Yan Hongtao, Su Yuhao, Chen Yahui, Wang Fei, Leng Zhengwei, Huang Xiaolun. Dendritic cell-related gene signature in pancreatic cancer stratifies patient subtypes and implicates a KCTD14-TNF signaling axis.. Frontiers in immunology. 2025. DOI: 10.3389/fimmu.2025.1665906.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.